Denali Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.

About DNLI

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.

CEO

Ryan J. Watts

CEORyan J. Watts

Employees

445

Employees445

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2013

Founded2013

Employees

445

Employees445

DNLI Key Statistics

Market cap

3.61B

Market cap3.61B

Price-Earnings ratio

-8.85

Price-Earnings ratio-8.85

Dividend yield

—

Dividend yield—

Average volume

804.68K

Average volume804.68K

High today

$25.50

High today$25.50

Low today

$24.47

Low today$24.47

Open price

$25.27

Open price$25.27

Volume

621.17K

Volume621.17K

52 Week high

$25.90

52 Week high$25.90

52 Week low

$14.56

52 Week low$14.56

Analyst ratings

93%

of 15 ratings

Buy

93.3%

Hold

6.7%

Sell